Inventor · disambiguated record
Stephen Andrew Thomson
Also filed as: THOMSON STEPHEN · THOMSON STEPHEN A · THOMSON STEPHEN ANDREW
19 granted patents·21 pending applications·88 citations·filing 1990–2025
93Inventor score
Files withVERTEX PHARMA26SMITHKLINE BEECHAM CORP3BANKER PIERETTE2GLAXOSMITHKLINE IP DEV LTD2BOYCE RUSTUM S1
Top patents by PatentIndex Score
40 records- 0195US11834441B2Substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2020·Granted Dec 5, 2023·4 cites·62 claims
- 0295US11827627B2N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Granted Nov 28, 2023·3 cites·37 claims
- 0395US10647661B2Carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2018·Granted May 12, 2020·15 cites·106 claims
- 0494US11919887B2Substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Granted Mar 5, 2024·2 cites·21 claims
- 0593US12247021B2Substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2023·Granted Mar 11, 2025·1 cites·24 claims
- 0693US11603351B2Carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2020·Granted Mar 14, 2023·3 cites·27 claims
- 0791US12281057B2Carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Granted Apr 22, 2025·1 cites·15 claims
- 0891US11884672B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2020·Granted Jan 30, 2024·4 cites·11 claims
- 0989US12331057B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2023·Granted Jun 17, 2025·1 cites·11 claims
- 1085US2025197381A1Substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 1182US6649366B2Methods and compositions related to modulators of annexin and cartilage homeostasisSMITHKLINE BEECHAM CORP·Filed 2000·Granted Nov 18, 2003·21 cites·3 claims
- 1282US5087631AOxathi(SIV)azol-5-one compoundsGLAXO INC·Filed 1990·Granted Feb 11, 1992·27 cites·12 claims
- 1380US12258333B2N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2023·Granted Mar 25, 2025·0 cites·22 claims
- 1479US11623924B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2019·Granted Apr 11, 2023·3 cites·15 claims
- 1569US2025353836A1N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2025·Application pending·0 cites
- 1668US2023265080A1Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 1760US2024246918A1Compounds and compositions as eif4e inhibitors and the uses thereofRIBOMETRIX INC·Filed 2023·Application pending·0 cites
- 1860US2024294512A1Hydroxy and (halo)alkoxy substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 1959US7625909B2Substituted quinazolinone compoundsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2004·Granted Dec 1, 2009·1 cites·21 claims
- 2058US2024400544A1N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamide analogs as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 2158US2024368135A1Substituted tetrahydrofuran-2-carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 2257US2025213555A1Substituted tetrahydrofuran analogs as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 2354US12502376B2Pyrano[4,3-b]indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD)VERTEX PHARMA·Filed 2021·Granted Dec 23, 2025·0 cites·33 claims
- 2454US11053234B21,3 di-substituted cyclobutane or azetidine derivatives as hematopoietic prostaglandin D synthase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Jul 6, 2021·0 cites·12 claims
- 2553US2023159502A1Indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)VERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2653US2023339915A1Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2753US2023159504A17- or 8-hydroxy-isoquinoline and 7- or 8-hydroxy-quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)VERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2852US2023159580A1Pyrrolo[2,3-f]indazole and 2,4,5,10-tetrazatricyclo[7.3.0.03,7]dodeca-1,3(7),5,8,11-pentaene derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)VERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2952US2023159521A11h-pyrazolo[4,3-g]isoquinoline and 1h-pyrazolo[4,3-g]quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)VERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3051US12440481B2Esters and carbamates as modulators of sodium channelsVERTEX PHARMA·Filed 2020·Granted Oct 14, 2025·0 cites·23 claims
- 3150US12441703B2Carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2020·Granted Oct 14, 2025·0 cites·23 claims
- 3250US2010105654A1Substituted quinazolinone compoundsBOYCE RUSTUM S·Filed 2009·Application pending·0 cites
- 3345US2010305207A1Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereofBANKER PIERETTE·Filed 2008·Application pending·0 cites
- 3445US2004053919A1Methods and compositions related to modulators of annexin and cartilage homeostasisFiled 2003·Application pending·0 cites
- 3542US2010234433A1Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereofBANKER PIERETTE·Filed 2008·Application pending·0 cites
- 3638US2005267133A1Pyrazolopyrimidines as kinase inhibitorsBROWN MATTHEW L·Filed 2003·Application pending·0 cites
- 3736US2021238162A1Chemical compoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Application pending·0 cites
- 3836US2007249670A1Glycogen Phosphorylase Inhibitor Compounds and Pharmaceutical Compositions ThereofSMITHKLINE BEECHAM CORP·Filed 2005·Application pending·0 cites
- 3934US2006167020A1Pyrazolopyrimidines as kinase inhibitorsDICKERSON SCOTT H·Filed 2003·Application pending·0 cites
- 4027US6589934B1Kv2.1 antagonistsSMITHKLINE BEECHAM CORP·Filed 1998·Granted Jul 8, 2003·2 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Stephen Andrew Thomson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →